DIAGNOSIS AND TREATMENT OF ANAPLASTIC LARGE-CELL LYMPHOMAS IN CHILDREN

被引：0

作者：

Valiev, T. T. ^{[1
]}

Morozova, O. V. ^{[1
]}

Kovrigina, A. M. ^{[2
]}

Makhonova, L. A. ^{[1
]}

Sholokhova, E. N. ^{[3
]}

Serebryakova, I. N. ^{[1
]}

Popa, A. V. ^{[1
]}

Tupitsyn, N. N. ^{[3
]}

Mentkevich, G. L. ^{[1
]}

机构：

[1] Russian Canc Res Ctr, NN Blokhin Inst Pediat Oncol & Hematol, Moscow 115478, Russia

[2] Russian Canc Res Ctr, Hematol Res Ctr, Moscow, Russia

[3] Russian Canc Res Ctr, Inst Clin Oncol, Moscow, Russia

来源：

GEMATOLOGIYA I TRANSFUZIOLOGIYA | 2012年 / 57卷 / 01期

关键词：

children; anaplastic large-cell lymphoma; diagnosis; therapy; EXPRESSION; ADOLESCENTS; NEOPLASMS; THERAPY; TRIAL;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Immunomorphological characteristics of anaplastic large-cell lymphomas (ALCL) in children, clinical features of ALCL, and results of its therapy by modern chemotherapy protocols are presented. Based on own experience and published data, the authors have modified the B-NHL-BFM95 protocol for the treatment of prognostically unfavorable ALCL variants, which led to improvement of patients' survival.

引用

页码：3 / 9

页数：7

共 18 条

[1] Pathobiology of ALK+ anaplastic large-cell lymphoma [J].

Amin, Hesham M. ;

Lai, Raymond .

BLOOD, 2007, 110 (07) :2259-2267

[2]

[Anonymous], 2010, GROUP

[3] Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma [J].

Asano, N. ;

Suzuki, R. ;

Matsuo, K. ;

Kagami, Y. ;

Ishida, F. ;

Tamaru, J-I ;

Jin, G-S ;

Sato, Y. ;

Shimoyama, Y. ;

Yoshino, T. ;

Morishima, Y. ;

Nakamura, S. .

HISTOPATHOLOGY, 2007, 50 (06) :705-715

[4] Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma [J].

Asano, Naoko ;

Suzuki, Ritsuro ;

Ohshima, Koichi ;

Kagami, Yoshitoyo ;

Ishida, Fumihiro ;

Yoshino, Tadashi ;

Ogawa, Hiroshi ;

Morishima, Yasuo ;

Nakamura, Shigeo .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (03) :426-435

[5] The expression of myeloid antigens CD13 and/or CD33 is a marker of ALK plus anaplastic large cell lymphomas [J].

Bovio, Ian M. ;

Allan, Robert W. .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (04) :628-634

[6] Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols [J].

Burkhardt, B. ;

Oschlies, I. ;

Klapper, W. ;

Zimmermann, M. ;

Woessmann, W. ;

Meinhardt, A. ;

Landmann, E. ;

Attarbaschi, A. ;

Niggli, F. ;

Schrappe, M. ;

Reiter, A. .

LEUKEMIA, 2011, 25 (01) :153-160

[7]

Foyil KV, 2011, IMMUNOTHERAPY-UK, V3, P475, DOI [10.2217/IMT.11.15, 10.2217/imt.11.15]

[8] Prognostic factors in childhood anaplastic large cell lymphoma:: results of a large European intergroup study [J].

Le Deley, Marie-Cecile ;

Reiter, Alfred ;

Williams, Denise ;

Delsol, Georges ;

Oschlies, Ilske ;

McCarthy, Keith ;

Zimmermann, Martin ;

Brugieres, Laurence .

BLOOD, 2008, 111 (03) :1560-1566

[9] Pediatric ALK+ anaplastic large cell lymphoma with t(3;8)(q26.2;q24) translocation and c-myc rearrangement terminating in a leukemic phase [J].

Monaco, Sara ;

Tsao, Lawrence ;

Murty, V. V. ;

Nandula, S. V. ;

Donovan, Virginia ;

Oesterheld, J. ;

Bhagat, Govind ;

Alobeid, Bachir .

AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (01) :59-64

[10] Diagnosis of paediatric anaplastic large-cell lymphoma: a historical perspective from a single institution [J].

Moreno, Lucas ;

Garzon, Lucia ;

Jose Bautista, Francisco ;

Fernandez Navarro, Jose Maria ;

del Mar Andres, Maria ;

Verdeguer, Amparo .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (05) :318-321

← 1 2 →